Literature DB >> 28868329

Active Cdk5 Immunoprecipitation and Kinase Assay.

Andrew N Bankston1,2, Li Ku1, Yue Feng1.   

Abstract

Cdk5 activity is regulated by the amounts of two activator proteins, p35 and p39 (Tsai et al., 1994; Zheng et al., 1998; Humbert et al., 2000). The p35-Cdk5 and p39-Cdk5 complexes have differing sensitivity to salt and detergent concentrations (Hisanaga and Saito, 2003; Sato et al., 2007; Yamada et al., 2007; Asada et al., 2008). Cdk5 activation can be directly measured by immunoprecipitation of Cdk5 with its bound activator, followed by a Cdk5 kinase assay. In this protocol, buffers for cell lysis and immunoprecipitation are intended to preserve both p35- and p39-Cdk5 complexes to assess total Cdk5 activity. Cells are lysed and protein concentration is determined in the post-nuclear supernatant. Cdk5 is immunoprecipitated from equal amounts of total protein between experimental groups. Washes are then performed to remove extraneous proteins and equilibrate the Cdk5-activator complexes in the kinase buffer. Cdk5 is then incubated with histone H1, a well-established in vitro target of Cdk5, and [γ-32P]ATP. Reactions are resolved by SDS-PAGE and transferred to membranes for visualization of H1 phosphorylation and immunoblot of immunoprecipitated Cdk5 levels. We have used this assay to establish p39 as the primary activator for Cdk5 in the oligodendroglial lineage. However, this assay is amenable to other cell lineages or tissues with appropriate adjustments made to lysis conditions.

Entities:  

Keywords:  Cdk5; Immunoblot; Kinase assay; Radiation; Western blot

Year:  2017        PMID: 28868329      PMCID: PMC5580939          DOI: 10.21769/BioProtoc.2363

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  15 in total

1.  Regulation of membrane association and kinase activity of Cdk5-p35 by phosphorylation of p35.

Authors:  Ko Sato; Ying-Shan Zhu; Taro Saito; Kensuke Yotsumoto; Akiko Asada; Masato Hasegawa; Shin-ichi Hisanaga
Journal:  J Neurosci Res       Date:  2007-11-01       Impact factor: 4.164

2.  Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.

Authors:  M Zheng; C L Leung; R K Liem
Journal:  J Neurobiol       Date:  1998-05

3.  Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes.

Authors:  X M Tang; P Strocchi; F Cambi
Journal:  J Cell Biochem       Date:  1998-01-01       Impact factor: 4.429

4.  p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.

Authors:  J Ko; S Humbert; R T Bronson; S Takahashi; A B Kulkarni; E Li; L H Tsai
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

5.  Hypomyelination phenotype caused by impaired differentiation of oligodendrocytes in Emx1-cre mediated Cdk5 conditional knockout mice.

Authors:  Xiaojuan He; Satoru Takahashi; Hiromi Suzuki; Tsutomu Hashikawa; Ashok B Kulkarni; Katsuhiko Mikoshiba; Toshio Ohshima
Journal:  Neurochem Res       Date:  2011-01-06       Impact factor: 3.996

6.  Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.

Authors:  T Ohshima; J M Ward; C G Huh; G Longenecker; H C Pant; R O Brady; L J Martin; A B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 7.  The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.

Authors:  Shin-ichi Hisanaga; Taro Saito
Journal:  Neurosignals       Date:  2003 Sep-Oct

8.  Cdk5 phosphorylation of WAVE2 regulates oligodendrocyte precursor cell migration through nonreceptor tyrosine kinase Fyn.

Authors:  Yuki Miyamoto; Junji Yamauchi; Akito Tanoue
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

9.  Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes.

Authors:  Akiko Asada; Naoyuki Yamamoto; Masaki Gohda; Taro Saito; Nobuhiro Hayashi; Shin-Ichi Hisanaga
Journal:  J Neurochem       Date:  2008-05-26       Impact factor: 5.372

10.  p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton.

Authors:  S Humbert; R Dhavan; L Tsai
Journal:  J Cell Sci       Date:  2000-03       Impact factor: 5.285

View more
  2 in total

1.  Protocols for Characterization of Cdk5 Kinase Activity.

Authors:  Anita Terse; Niranjana Amin; Bradford Hall; Manju Bhaskar; Binukumar B K; Elias Utreras; Tej K Pareek; Harish Pant; Ashok B Kulkarni
Journal:  Curr Protoc       Date:  2021-10

2.  Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism.

Authors:  Qingxin Zhou; Meihua Lin; Xing Feng; Fei Ma; Yuekun Zhu; Xing Liu; Chao Qu; Hong Sui; Bei Sun; Anlong Zhu; Heng Zhang; He Huang; Zhi Gao; Yongxiang Zhao; Jiangyun Sun; Yuxian Bai; Junfei Jin; Xuehui Hong; Chang Zou; Zhiyong Zhang
Journal:  J Exp Med       Date:  2020-08-03       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.